Blog Archives
Owen Davis, Contour and NYC Seed
Welcome to my series on OG NY Tech — celebrating 30 years of NY tech ecosystem, from 1995 to now. Owen Davis tells us how advertising powered early NYC tech and the big transition post-dot-com-crash to both consumer and enterprise
Owen Davis, Contour and NYC Seed
Welcome to my series on OG NY Tech — celebrating 30 years of NY tech ecosystem, from 1995 to now. Owen Davis tells us how advertising powered early NYC tech and the big transition post-dot-com-crash to both consumer and enterprise
John Borthwick, Betaworks
Welcome to my series on OG NY Tech — celebrating 30 years of NY tech ecosystem, from 1995 to now. John Borthwick tells us the roots story of media and art and agencies at the heart of the early NY
John Borthwick, Betaworks
Welcome to my series on OG NY Tech — celebrating 30 years of NY tech ecosystem, from 1995 to now. John Borthwick tells us the roots story of media and art and agencies at the heart of the early NY
Pablos Holman from Deep Future VC on “invention” vs. just innovation
Pablos built one of the first decentralized money networks, the first experimental Blue Origin rockets, one of the first handheld computers, invented 1000s of new patents with Nathan Myhrvold, and most recently launched a deeptech venture firm called Deep Future.
Pablos Holman from Deep Future VC on “invention” vs. just innovation
Pablos built one of the first decentralized money networks, the first experimental Blue Origin rockets, one of the first handheld computers, invented 1000s of new patents with Nathan Myhrvold, and most recently launched a deeptech venture firm called Deep Future.
AI x Bio x NY: highlights from our conference
So you missed the all-day all-science+technology collection of superstars gathered by LifeX and Bits in Bio at Fenwick in New York? Wondering what the frontiers of foundation models in bio, longevity, startups and more are pushing? Now you can use
AI x Bio x NY: highlights from our conference
So you missed the all-day all-science+technology collection of superstars gathered by LifeX and Bits in Bio at Fenwick in New York? Wondering what the frontiers of foundation models in bio, longevity, startups and more are pushing? Now you can use
What’s super-investor Jim Mellon thinking about?
Jim, founder of Juvenescence, old China and Russia hand, and investor in our fund LifeX sends me an email every morning with lots of attachments that he read that morning. Here’s what he’s been thinking about the last month.
What’s super-investor Jim Mellon thinking about?
Jim, founder of Juvenescence, old China and Russia hand, and investor in our fund LifeX sends me an email every morning with lots of attachments that he read that morning. Here’s what he’s been thinking about the last month.
De-growth, de-acceleration from the Slow Down manifesto by Shohei Saito, by Amolbot
Read the post here: https://amol.sarva.co/%f0%9f%90%8c-kohei-saitos-slow-down-de-acc-manifesto/
De-growth, de-acceleration from the Slow Down manifesto by Shohei Saito, by Amolbot
Read the post here: https://amol.sarva.co/%f0%9f%90%8c-kohei-saitos-slow-down-de-acc-manifesto/
Cyborgs! Our AI and Bio Future, by Amolbot
I gave a talk in Stockholm last year, that I asked these robots to discuss. Hope you enjoy it. This doesn’t look LIKE me but it does sort of resemble what I could possibly look like. It was the first
Cyborgs! Our AI and Bio Future, by Amolbot
I gave a talk in Stockholm last year, that I asked these robots to discuss. Hope you enjoy it. This doesn’t look LIKE me but it does sort of resemble what I could possibly look like. It was the first
What’s Om Malik interested in these days?
The first ten-ish installments of Om’s new publication.
10 x Trends for AI x Health + Bio in 2025 from LifeX dealflow analysis, courtesy of Amolbot
We analyzed the 1,000s of companies we’re watching and investing in at LifeX. We looked at every update email from every CEO and every conversation notes from every team member. And we made hits outlook for the year ahead, automagically.
10 x Trends for AI x Health + Bio in 2025 from LifeX dealflow analysis, courtesy of Amolbot
We analyzed the 1,000s of companies we’re watching and investing in at LifeX. We looked at every update email from every CEO and every conversation notes from every team member. And we made hits outlook for the year ahead, automagically.
20 Trends for 2025 in Health and Biopharma from Wall Street, synthesized by Amolbot
We synthesized the dozens of outlook reports from Wall Street analysts on health, biopharma, and related trends. Listen in to Amolbot (an automated Amol) and co-hosts.
20 Trends for 2025 in Health and Biopharma from Wall Street, synthesized by Amolbot
We synthesized the dozens of outlook reports from Wall Street analysts on health, biopharma, and related trends. Listen in to Amolbot (an automated Amol) and co-hosts.
You must be logged in to post a comment.